Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Calidi Biotherapeutics (CLDI) has shared an update.
David LaPre has stepped down from his role as a director of Calidi Biotherapeutics, Inc., including all board committee positions, effective immediately. His resignation is not due to any disagreements with the company’s operations, policies, or practices.
Find detailed analytics on CLDI stock on TipRanks’ Stock Analysis page.